Quantcast
Last updated on April 21, 2014 at 5:21 EDT

Latest Ventricular assist device Stories

2012-12-13 12:24:18

CHICAGO, Dec. 13, 2012 /PRNewswire/ -- Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include Thoratec Corp (Nasdaq:THOR), HeartWare (Nasdaq:HTWR), Merit Medical (Nasdaq:MMSI), Mesa Laboratories (Nasdaq:MLAB) and Cantel Medical (NYSE:CMN). (Logo: http://photos.prnewswire.com/prnh/20101027/ZIRLOGO) Get the most...

2012-12-11 08:28:02

PLEASANTON, Calif., Dec. 11, 2012 /PRNewswire/ -- Thoratec Corporation (NASDAQ: THOR), a world leader in device-based mechanical circulatory support therapies to save, support and restore failing hearts, announced today that the company has received approval from Japan's Ministry of Health, Labour and Welfare to market HeartMate II®( )as a Bridge-to-Transplantation therapy for patients suffering from advanced heart failure. "Approval in Japan marks a significant milestone in Thoratec's...

2012-12-10 16:23:34

PLEASANTON, Calif., Dec. 10, 2012 /PRNewswire/ -- Thoratec Corporation (NASDAQ: THOR), a world leader in device-based mechanical circulatory support therapies to save, support and restore failing hearts, said today it will be participating in the Oppenheimer 23(rd) Annual Healthcare Conference on Wednesday, December 12. Taylor C. Harris, Vice President and Chief Financial Officer, will provide an update on the company beginning at 10:35 a.m., Eastern Standard Time (7:35 a.m., Pacific...

2012-12-06 12:26:49

TUCSON, Ariz., Dec. 6, 2012 /PRNewswire/ -- SynCardia Systems, Inc. (www.syncardia.com), manufacturer of the world's first and only FDA, Health Canada and CE (Europe) approved Total Artificial Heart, announced today that University of Washington (UW) Medical Center in Seattle has performed 10 implants of the SynCardia temporary Total Artificial Heart so far in 2012, the most of any SynCardia Certified Center this year. It also marks a new record for number of implants performed by a hospital...

2012-12-06 08:27:56

FRAMINGHAM, Mass. and SYDNEY, Dec. 6, 2012 /PRNewswire/ -- HeartWare International, Inc. (NASDAQ: HTWR - ASX: HIN), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced that CEO Doug Godshall is scheduled to present at the Oppenheimer 23(rd )Annual Healthcare Conference at 10:00 a.m. EST on Thursday, December 13, 2012. The conference is being held December 12-13 at the...

2012-11-26 08:24:46

PLEASANTON, Calif., Nov. 26, 2012 /PRNewswire/ -- Thoratec Corporation (NASDAQ: THOR), a world leader in device-based mechanical circulatory support therapies to save, support and restore failing hearts, announced today that its Board of Directors has authorized the repurchase of up to $150 million of the company's shares of common stock. The company's prior authorization expired in early November. As part of the new authorization, the company has entered into a $75 million Accelerated...

2012-11-20 16:28:41

FRAMINGHAM, Mass. and SYDNEY, Nov. 20, 2012 /PRNewswire/ -- HeartWare International, Inc. (Nasdaq: HTWR; ASX: HIN), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced that it has received approval from the United States Food and Drug Administration (FDA) for the HeartWare(®) Ventricular Assist System as a bridge to heart transplantation in patients with...

2012-11-16 16:23:29

FRAMINGHAM, Mass. and SYDNEY, Nov. 16, 2012 /PRNewswire/ -- HeartWare International, Inc. (NASDAQ: HTWR - ASX: HIN), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced that CEO Doug Godshall is scheduled to present at the 24(th) Annual Piper Jaffray Healthcare Conference at 8:30 a.m. EST on Wednesday, November 28, 2012. The conference is being held November 27-28, 2012, at The...

2012-11-15 08:32:00

TUCSON, Ariz., Nov. 15, 2012 /PRNewswire/ -- SynCardia Systems, Inc. (www.syncardia.com), manufacturer of the world's first and only FDA, Health Canada and CE (Europe) approved Total Artificial Heart, announced today that avid hiker Chris Marshall, who received the SynCardia temporary Total Artificial Heart in February, has been successfully bridged to a heart transplant at University of Washington (UW) Medical Center in Seattle. (Photo: http://photos.prnewswire.com/prnh/20121115/LA13969)...

2012-11-12 16:25:54

PLEASANTON, Calif., Nov. 12, 2012 /PRNewswire/ -- Thoratec Corporation (NASDAQ: THOR), a world leader in device-based mechanical circulatory support therapies to save, support and restore failing hearts, said today it will be participating in the Credit Suisse 2012 Healthcare Conference on Thursday, November 15. Taylor C. Harris, Vice President and Chief Financial Officer, will provide an update on the company beginning at 9 a.m., Mountain Standard Time (11 a.m., Eastern Standard Time). The...


Latest Ventricular assist device Reference Libraries

0_886104d1c1c698f3a531e056704457d5
2010-10-14 16:46:25

The artificial heart, a mechanical heart replacement, is typically used in order to bridge the time to heart transplant or to replace the heart in case a transplant is impossible. Often ventricular assist devices are confused with mechanical hearts because the assist the heart through pumps. They are also different from a cardiopulmonary bypass machine which is an external device used to provide the function of the heart and lungs. CPBs are usually only used for a few hours at a time,...

More Articles (1 articles) »